Literature DB >> 27488133

Skeletal complications in cancer patients with bone metastases.

Shunsuke Tsuzuki1, Sun Hee Park1, Matthew R Eber1, Christopher M Peters2, Yusuke Shiozawa3.   

Abstract

As a result of significant improvements in current therapies, the life expectancy of cancer patients with bone metastases has dramatically improved. Unfortunately, these patients often experience skeletal complications that significantly impair their quality of life. The major skeletal complications associated with bone metastases include: cancer-induced bone pain, hypercalcemia, pathological bone fractures, metastatic epidural spinal cord compression and cancer cachexia. Once cancer cells invade the bone, they perturb the normal physiology of the marrow microenvironment, resulting in bone destruction, which is believed to be a direct cause of skeletal complications. However, full understanding of the mechanisms responsible for these complications remains unknown. In the present review, we discuss the complications associated with bone metastases along with matched conventional therapeutic strategies. A better understanding of this topic is crucial, as targeting skeletal complications can improve both the morbidity and mortality of patients suffering from bone metastases.
© 2016 The Japanese Urological Association.

Entities:  

Keywords:  bone metastasis; cancer-induced bone pain; hypercalcemia; metastatic epidural spinal cord compression; pathological bone fractures; skeletal complications

Mesh:

Year:  2016        PMID: 27488133      PMCID: PMC5718365          DOI: 10.1111/iju.13170

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  110 in total

1.  Metastasis size in pathologic femoral fractures.

Authors:  H Menck; S Schulze; E Larsen
Journal:  Acta Orthop Scand       Date:  1988-04

Review 2.  Involvement of activin in the regulation of bone metabolism.

Authors:  R Sakai; Y Eto
Journal:  Mol Cell Endocrinol       Date:  2001-06-30       Impact factor: 4.102

Review 3.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

4.  Phase 3, randomized, placebo-controlled study of zibotentan (ZD4054) in patients with castration-resistant prostate cancer metastatic to bone.

Authors:  Joel B Nelson; Karim Fizazi; Kurt Miller; Celestia Higano; Judd W Moul; Hideyuki Akaza; Thomas Morris; Stuart McIntosh; Kristine Pemberton; Martin Gleave
Journal:  Cancer       Date:  2012-07-11       Impact factor: 6.860

5.  Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats.

Authors:  Maree T Smith; Bruce D Wyse; Stephen R Edwards
Journal:  Pain Med       Date:  2013-03-14       Impact factor: 3.750

Review 6.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

7.  Nerve growth factor is a potential therapeutic target in breast cancer.

Authors:  Eric Adriaenssens; Elsa Vanhecke; Pasquine Saule; Alexandra Mougel; Adeline Page; Rodrigue Romon; Victor Nurcombe; Xuefen Le Bourhis; Hubert Hondermarck
Journal:  Cancer Res       Date:  2008-01-15       Impact factor: 12.701

8.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 9.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  Intraspinal neuroblastoma: Treatment options and neurological outcome of spinal cord compression.

Authors:  Mohamed Fawzy; Mohamed El-Beltagy; Maged El Shafei; Mohamed Saad Zaghloul; Naglaa Al Kinaai; Amal Refaat; Sarah Azmy
Journal:  Oncol Lett       Date:  2014-12-12       Impact factor: 2.967

View more
  38 in total

1.  Prophylactic Percutaneous Consolidation of Large Osteolytic Tumors of the Pelvic Ring Using Fixation by Internal Cemented Screws.

Authors:  Jessica Assouline; Lambros Tselikas; Charles Roux; Steven Yevich; Alexandre Delpla; Arash Najafi; Marc Al Ahmar; Jean-Charles Bijot; Thierry de Baère; Frédéric Deschamps
Journal:  Radiol Imaging Cancer       Date:  2021-05

Review 2.  Percutaneous Fixation by Internal Cemented Screw for the Treatment of Unstable Osseous Disease in Cancer Patients.

Authors:  Frederic Deschamps; Steven Yevich; Guillaume Gravel; Charles Roux; Antoine Hakime; Thierry de Baère; Lambros Tselikas
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

3.  Aggressive denosumab-related jaw necrosis - a case series.

Authors:  M Badr; E Kyriakidou; S Atkins; S Harrison
Journal:  Br Dent J       Date:  2017-07-07       Impact factor: 1.626

4.  The role of methadone in cancer-induced bone pain: a retrospective cohort study.

Authors:  Merlina Sulistio; Robert Wojnar; Seraphina Key; Justin Kwok; Ziad Al-Rubaie; Natasha Michael
Journal:  Support Care Cancer       Date:  2020-07-06       Impact factor: 3.603

Review 5.  Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis.

Authors:  Sun H Park; Evan T Keller; Yusuke Shiozawa
Journal:  Calcif Tissue Int       Date:  2017-11-01       Impact factor: 4.333

6.  Cryoablation for Palliation of Painful Bone Metastases: The MOTION Multicenter Study.

Authors:  Jack W Jennings; J David Prologo; Julien Garnon; Afshin Gangi; Xavier Buy; Jean Palussière; A Nicholas Kurup; Matthew Callstrom; Scott Genshaft; Fereidoun Abtin; Ambrose J Huang; Jason Iannuccilli; Frank Pilleul; Charles Mastier; Peter J Littrup; Thierry de Baère; Frédéric Deschamps
Journal:  Radiol Imaging Cancer       Date:  2021-02-12

7.  Percutaneous reinforced osteoplasty for long bone metastases: a feasibility study.

Authors:  Nischal Koirala; Gordon McLennan
Journal:  Skeletal Radiol       Date:  2019-08-04       Impact factor: 2.199

8.  Potentiating bisphosphonate-based coordination complexes to treat osteolytic metastases.

Authors:  Gabriel Quiñones Vélez; Lesly Carmona-Sarabia; Waldemar A Rodríguez-Silva; Alondra A Rivera Raíces; Lorraine Feliciano Cruz; Tony Hu; Esther Peterson; Vilmalí López-Mejías
Journal:  J Mater Chem B       Date:  2020-03-11       Impact factor: 6.331

9.  Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis.

Authors:  Sivakumar Vijayaraghavalu; Yue Gao; Mohammed Tanjimur Rahman; Richard Rozic; Nima Sharifi; Ronald J Midura; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2019-10-18       Impact factor: 12.479

10.  Hypercalcaemia, Renal Dysfunction, Anaemia, Bone Disease (CRAB Criteria): A Case of Lymphoma.

Authors:  Balraj Singh; Pooja Gogia; Parminder Kaur; Nirmal Guragai; Michael Maroules
Journal:  Eur J Case Rep Intern Med       Date:  2020-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.